Thermo Fisher Scientific Inc.
TMO Healthcare Diagnostics & Research
Thermo Fisher Scientific Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.6 billion, up 3.91% from fiscal 2024. In the quarter to June 2026, revenue grew 10.5%, EPS grew 9.35%, free cash flow grew 51.8% and total debt rose 18.7%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.
Follow TMO
Thermo Fisher Scientific Inc. (TMO) Total debt
Thermo Fisher Scientific Inc.'s total debt at the end of fiscal 2025 was $35.9B, up 23.4% from $29.1B in fiscal 2024. At the end of the quarter to 30 June 2026 it was $39.2B. Over the past ten years it has ranged from $11.4B (fiscal 2015) to $35.9B (fiscal 2025) — the current reading is the highest in ten years. Thermo Fisher Scientific Inc. ranks 1st of 50 Diagnostics & Research companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $35.9B | 23.37% |
| FY2024 | $29.1B | (7.18%) |
| FY2023 | $31.3B | 8.30% |
| FY2022 | $28.9B | (10.59%) |
| FY2021 | $32.3B | 69.22% |
| FY2020 | $19.1B | 11.89% |
| FY2019 | $17.1B | (3.63%) |
| FY2018 | $17.7B | (6.11%) |
| FY2017 | $18.9B | 22.78% |
| FY2016 | $15.4B | 34.60% |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Jun 2026 | $39.2B | (2.22%) |
| Mar 2026 | $40.1B | 11.77% |
| Dec 2025 | $35.9B | 12.54% |
| Sep 2025 | $31.9B | (3.51%) |
| 42 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| TMO Thermo Fisher Scientific Inc. | $39.2B |
| DHR Danaher Corporation compare | $25.1B |
| IQV IQVIA Holdings Inc. compare | $16.0B |
| WAT Waters Corporation compare | $4.9B |
| A Agilent Technologies, Inc. compare | $3.6B |
| MTD Mettler-Toledo International, Inc. compare | $2.1B |
| ILMN Illumina, Inc. compare | $1.5B |
| IDXX IDEXX Laboratories, Inc. compare | $449.9M |
| NTRA Natera, Inc. compare | $80.3M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on TMO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement